Health
GSK raises $1.24bn from latest Haleon share sale
British drugmaker GSK said Wednesday it received 978 million pounds ($1.24 billion) from the discounted sale of Haleon shares, reducing its stake to 4.2 per
US approves Vertex/CRISPR gene therapy to treat inherited blood disorder
U.S. health regulator has approved Vertex Pharmaceuticals’ CRISPR Therapeutics’. A gene therapy to treat a rare blood disorder requiring regular blood transfusions in patients 12
Union opposes possible Bayer spin-off
The German trade union IG BCE has opposed a possible split at Bayer Pharmaceuticals, which some shareholders are planning, on the grounds that it would
WHO requested $1.5 billion to address crises from Gaza to Afghanistan
The World Health Organisation has applied for $1.5 billion in funding to address the health needs of millions of people caught up in dozens of
Global tobacco use declines
Global tobacco consumption has fallen in a generation: one in five people smoke, down from one in three in 2000, the World Health Organisation reported.
Artificial heart maker Carmat will soon launch a capital raise
French artificial heart maker Carmat said Monday it will soon launch a capital increase estimated to raise at least 50 million euros ($54.8 million) to
Gates Foundation gets record budget
The Bill & Melinda Gates Foundation plans to spend more this year than ever before, $8.6 billion, at a time when overall healthcare funding for
WHO sees “incredibly low” COVID and flu vaccination rates
Low vaccination rates against the latest versions of the COVID-19 virus and influenza are putting pressure on healthcare systems this winter. In the United States,
WHO declares Cape Verde malaria-free
The World Health Organisation has declared Cape Verde malaria-free, calling it a milestone in the fight against the disease. According to the WHO, Cape Verde
Novo Nordisk resumes supply of Vegovi in 1.7 mg dose in the US
Novo Nordisk said it resumed supplies of its weight-loss drug Wegovy at a dose of 1.7 milligrams in early January after a short-term shortage in